Contact: firstname.lastname@example.org 617-492-5900
Insights to understand growth and development opportunities to achieve and retain market share, capture customers and improve the top-line.
Enhance your organization’s market position and brand perception through strategies that improve value, create differentiation, and address disruption.
Navigate today's and tomorrow’s competitive marketplace and enhance your strategic decision-making with concrete insights about the external environment.
Expand your company’s marketing reach with data-rich thought leadership research, analysis, data visualization, and report writing services.
Insights » BioPharma
Background + Challenge A pharmaceutical client in the oncology market was in need of effectively tracking the developmental programs of […]
Background + Challenge A pharmaceutical company with a testosterone replacement product lacked visibility into the testosterone diagnostic market and wished […]
Background + Challenge A molecular diagnostics company wished to confirm internal intelligence and dig deeper into the development of a […]
This proprietary qualitative analysis identifies five top pharmaceutical companies that stand out as major disruptors. Fuld + Company’s analysis includes […]
Varun Naik was called upon by PM360 to share best practices on Effectively Developing a Patient Support Program by Leveraging Competitive […]
This assessment of Wearables in clinial trials was originally published in: Clinical Leader Advancements in biosensor technology are becoming increasingly common in […]
Background + Challenge The top leadership of a leading global pharmaceutical company decided to enter an extremely fast-moving but potentially […]
Biosimilars were expected to spark competition and lower prices for branded biologics, but this potential has still been unfulfilled. The […]
Capitalism has its flaws. Economists as diverse as Adam Smith to Karl Marx would agree to this premise. Yet one […]
Background A mid-size specialty pharmaceutical company was interested in licensing promising early-stage compounds in order to add critical mass to […]
Background A biologic drug, with annual sales over $1 billion, offered a tempting target for nearly a dozen pharma companies […]
Background In order to compete more effectively in the market, a maker of specialist drugs for chronic conditions wanted to […]
131 Oliver Street
Boston, MA 02110 USA
+1 617 492 5900
6th Floor, Tower B
+91 (0)120 437 1132
42 Upper Berkeley Street
London, W1H 5PW
+44(0)203 752 6572
2 Kallang Avenue
#06-30 CT Hub
Copyright © 2018, Fuld + Company. All Rights Reserved.
Yelling Mule - Boston Web Design